Astera Labs (NASDAQ:ALAB) Trading 7% Higher – What’s Next?

Astera Labs, Inc. (NASDAQ:ALAB)’s share price was up 7% during trading on Friday . The company traded as high as $186.60 and last traded at $186.7340. Approximately 2,624,011 shares changed hands during mid-day trading, a decline of 46% from the average daily volume of 4,833,689 shares. The stock had previously closed at $174.45.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on ALAB. JPMorgan Chase & Co. upped their price target on shares of Astera Labs from $180.00 to $215.00 and gave the company an “overweight” rating in a research report on Wednesday, November 5th. Wall Street Zen downgraded Astera Labs from a “buy” rating to a “hold” rating in a research note on Tuesday, November 11th. Needham & Company LLC upped their target price on Astera Labs from $205.00 to $220.00 and gave the company a “buy” rating in a report on Wednesday, November 5th. BNP Paribas started coverage on Astera Labs in a research note on Thursday, November 20th. They issued an “outperform” rating for the company. Finally, Jefferies Financial Group reissued a “buy” rating on shares of Astera Labs in a research report on Wednesday, December 3rd. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and eight have given a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $190.63.

Astera Labs Price Performance

The stock has a market capitalization of $30.88 billion, a price-to-earnings ratio of 164.74, a price-to-earnings-growth ratio of 2.35 and a beta of 1.50. The stock has a 50-day moving average of $159.47 and a 200 day moving average of $165.12.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.10. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The business had revenue of $230.58 million for the quarter, compared to analyst estimates of $206.42 million. During the same period last year, the company earned $0.23 EPS. The firm’s revenue was up 103.9% on a year-over-year basis. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. Sell-side analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 90,459 shares of the business’s stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the completion of the transaction, the chief executive officer owned 2,080,418 shares of the company’s stock, valued at approximately $301,015,680.42. The trade was a 4.17% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Michael Truett Tate sold 11,430 shares of Astera Labs stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $144.69, for a total transaction of $1,653,806.70. Following the sale, the chief financial officer directly owned 192,297 shares in the company, valued at $27,823,452.93. This trade represents a 5.61% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 576,936 shares of company stock worth $87,409,540 over the last quarter. 12.50% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Astera Labs

Hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. boosted its stake in shares of Astera Labs by 29.6% during the second quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock valued at $1,089,491,000 after purchasing an additional 2,751,747 shares in the last quarter. Amundi raised its holdings in Astera Labs by 1,298.6% in the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after buying an additional 1,319,643 shares during the last quarter. FengHe Fund Management Pte. Ltd. bought a new position in Astera Labs in the 2nd quarter valued at approximately $106,772,000. Rafferty Asset Management LLC acquired a new stake in Astera Labs during the 3rd quarter worth approximately $209,599,000. Finally, BNP Paribas Financial Markets grew its holdings in Astera Labs by 577.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock worth $220,733,000 after acquiring an additional 960,899 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.